Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.48 |
| ▸ | CNR2 | P34972 | 2/20 | 0.48 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | KDM2B | Q8NHM5 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.41 |
| ▸ | NTRK3 | Q16288 | 1/20 | 0.40 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.40 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15743806 | 0.86 | CNR1 (0.51) | CNR1CNR2GRIN2BTSHRKDM2B | |
| SCHEMBL2477407 | 0.85 | CNR2 (0.55) | CNR1CNR2GRIN2BTSHRKDM2B | |
| SCHEMBL2475715 | 0.85 | CNR2 (0.55) | CNR1CNR2GRIN2BTSHRKDM2B | |
| SCHEMBL13570410 | 0.84 | CNR2 (0.53) | CNR1CNR2GRIN2BTSHRKDM2B | |
| SCHEMBL14664075 | 0.83 | CNR1 (0.48) | CNR1CNR2GRIN2BTSHRKDM2B | |
| SCHEMBL19688670 | 0.81 | CNR2 (0.46) | CNR1CNR2GRIN2BTSHRKDM2B | |
| SCHEMBL19688671 | 0.81 | CYP3A4 (0.49) | CNR1CNR2GRIN2BTSHRGAA | |
| Trifluoroacetic Acid SCHEMBL30345244 | 0.79 | CNR1 (0.49) | CNR1CNR2GRIN2BTSHRKDM2B | |
| SCHEMBL25793103 | 0.79 | L3MBTL1 (0.49) | ALDH1A1CYP3A4KMT2A | |
| SCHEMBL19688673 | 0.78 | CNR1 (0.46) | CNR1CNR2GRIN2BTSHRGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130085147-A1 | Hepatitis C Virus Inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130085147-A1 | Hepatitis C Virus Inhibitors | HAVCR2, MAVS, GTF3C1 | CNR1 4439/4885CNR2 4697/4885GRIN2B 4830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.